Lakefront Biotherapeutics | GLPG - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
argenx SE USD 44.38B 7.45B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Incyte USD 18.73B 660M 2026-03
Merck EUR 46.78B 6.52B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 307.76B 15.54B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
UCB EUR 46.41B 13.94B 2025-12
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03